News

Recent research suggests that CBN (cannabinol)—once known only for sleep support—may hold groundbreaking potential for eye health. Studies show CBN can protect retinal ganglion cells, help regulate intraocular pressure (IOP), and remodel the extracellular matrix in glaucoma models, all while engaging the body’s endocannabinoid system (ECS) to reduce oxidative stress and inflammation.

While human clinical trials are still in progress, peer-reviewed studies (PubMed 34921975, Frontiers in Medicine 2025) show that cannabinoids—especially CBN—could one day redefine neuro-retinal therapy.

In short: CBN is emerging as the eye’s quiet bodyguard—shielding neurons, balancing pressure, and preserving vision for the long haul. 👁️✨